BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 34243013)

  • 1. Etoposide, an anticancer drug involved in therapy-related secondary leukemia: Enzymes at play.
    Zhang W; Gou P; Dupret JM; Chomienne C; Rodrigues-Lima F
    Transl Oncol; 2021 Oct; 14(10):101169. PubMed ID: 34243013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human CREBBP acetyltransferase is impaired by etoposide quinone, an oxidative and leukemogenic metabolite of the anticancer drug etoposide through modification of redox-sensitive zinc-finger cysteine residues.
    Zhang W; Berthelet J; Michail C; Bui LC; Gou P; Liu R; Duval R; Renault J; Dupret JM; Guidez F; Chomienne C; Rodrigues Lima F
    Free Radic Biol Med; 2021 Jan; 162():27-37. PubMed ID: 33278510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etoposide quinone is a redox-dependent topoisomerase II poison.
    Jacob DA; Mercer SL; Osheroff N; Deweese JE
    Biochemistry; 2011 Jun; 50(25):5660-7. PubMed ID: 21595477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-Cell Protein Tyrosine Phosphatase Is Irreversibly Inhibited by Etoposide-Quinone, a Reactive Metabolite of the Chemotherapy Drug Etoposide.
    Nian Q; Berthelet J; Zhang W; Bui LC; Liu R; Xu X; Duval R; Ganesan S; Leger T; Chomienne C; Busi F; Guidez F; Dupret JM; Rodrigues Lima F
    Mol Pharmacol; 2019 Aug; 96(2):297-306. PubMed ID: 31221825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etoposide quinone is a covalent poison of human topoisomerase IIβ.
    Smith NA; Byl JA; Mercer SL; Deweese JE; Osheroff N
    Biochemistry; 2014 May; 53(19):3229-36. PubMed ID: 24766193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etoposide metabolites enhance DNA topoisomerase II cleavage near leukemia-associated MLL translocation breakpoints.
    Lovett BD; Strumberg D; Blair IA; Pang S; Burden DA; Megonigal MD; Rappaport EF; Rebbeck TR; Osheroff N; Pommier YG; Felix CA
    Biochemistry; 2001 Feb; 40(5):1159-70. PubMed ID: 11170441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioflavonoids cause DNA double-strand breaks and chromosomal translocations through topoisomerase II-dependent and -independent mechanisms.
    Goodenow D; Emmanuel F; Berman C; Sahyouni M; Richardson C
    Mutat Res Genet Toxicol Environ Mutagen; 2020 Jan; 849():503144. PubMed ID: 32087851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorpyrifos Induces MLL Translocations Through Caspase 3-Dependent Genomic Instability and Topoisomerase II Inhibition in Human Fetal Liver Hematopoietic Stem Cells.
    Lu C; Liu X; Liu C; Wang J; Li C; Liu Q; Li Y; Li S; Sun S; Yan J; Shao J
    Toxicol Sci; 2015 Oct; 147(2):588-606. PubMed ID: 26198043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etoposide catechol is an oxidizable topoisomerase II poison.
    Jacob DA; Gibson EG; Mercer SL; Deweese JE
    Chem Res Toxicol; 2013 Aug; 26(8):1156-8. PubMed ID: 23863110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Role for VCP/p97 in the Processing of Drug-Stabilized TOP2-DNA Covalent Complexes.
    Swan RL; Cowell IG; Austin CA
    Mol Pharmacol; 2021 Jul; 100(1):57-62. PubMed ID: 33941661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation.
    Lovett BD; Lo Nigro L; Rappaport EF; Blair IA; Osheroff N; Zheng N; Megonigal MD; Williams WR; Nowell PC; Felix CA
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9802-7. PubMed ID: 11493704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model for MLL translocations in therapy-related leukemia involving topoisomerase IIβ-mediated DNA strand breaks and gene proximity.
    Cowell IG; Sondka Z; Smith K; Lee KC; Manville CM; Sidorczuk-Lesthuruge M; Rance HA; Padget K; Jackson GH; Adachi N; Austin CA
    Proc Natl Acad Sci U S A; 2012 Jun; 109(23):8989-94. PubMed ID: 22615413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MLL rearrangements are induced by low doses of etoposide in human fetal hematopoietic stem cells.
    Moneypenny CG; Shao J; Song Y; Gallagher EP
    Carcinogenesis; 2006 Apr; 27(4):874-81. PubMed ID: 16377807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FEN1 participates in repair of the 5'-phosphotyrosyl terminus of DNA single-strand breaks.
    Kametani Y; Takahata C; Narita T; Tanaka K; Iwai S; Kuraoka I
    Carcinogenesis; 2016 Jan; 37(1):56-62. PubMed ID: 26581212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of chromosomal damage induced by etoposide in G2 phase in a DNA-PKcs-deficient context.
    Palmitelli M; de Campos-Nebel M; González-Cid M
    Chromosome Res; 2015 Dec; 23(4):719-32. PubMed ID: 26152239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal DNA topoisomerase II cleavage events at 5'-TATTA-3' sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processing.
    Whitmarsh RJ; Saginario C; Zhuo Y; Hilgenfeld E; Rappaport EF; Megonigal MD; Carroll M; Liu M; Osheroff N; Cheung NK; Slater DJ; Ried T; Knutsen T; Blair IA; Felix CA
    Oncogene; 2003 Nov; 22(52):8448-59. PubMed ID: 14627986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics and regulation of cytochrome P450-mediated etoposide metabolism.
    Zhuo X; Zheng N; Felix CA; Blair IA
    Drug Metab Dispos; 2004 Sep; 32(9):993-1000. PubMed ID: 15319341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleolytic cleavage of the mixed lineage leukemia breakpoint cluster region during apoptosis.
    Sim SP; Liu LF
    J Biol Chem; 2001 Aug; 276(34):31590-5. PubMed ID: 11406628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of tyrosyl DNA phosphodiesterase 2 activity enhances etoposide-mediated double-strand break formation and cell killing.
    Kont YS; Dutta A; Mallisetty A; Mathew J; Minas T; Kraus C; Dhopeshwarkar P; Kallakury B; Mitra S; Üren A; Adhikari S
    DNA Repair (Amst); 2016 Jul; 43():38-47. PubMed ID: 27235629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloperoxidase Enhances Etoposide and Mitoxantrone-Mediated DNA Damage: A Target for Myeloprotection in Cancer Chemotherapy.
    Atwal M; Lishman EL; Austin CA; Cowell IG
    Mol Pharmacol; 2017 Jan; 91(1):49-57. PubMed ID: 27974636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.